Trials / Completed
CompletedNCT00886444
Comparative Evaluation of Various Combinable Magnetic Resonance (CMR) Pulse-sequences for Macrophage Imaging Using Ferucarbotran
Comparative Evaluation of Various CMR Pulse-Sequences for Macrophage Imaging Using Ferucarbotran as Molecular Contrast Agent in Human Myocardial Infarction
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF) · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to: * clarify whether macrophage imaging using ferucarbotran is able to delineate the region of myocardial infarction as accurate as gadolinium-based necrosis/fibrosis imaging; * identify possible differences in infarct imaging using ferucarbotran for macrophage imaging compared to necrosis/fibrosis imaging with gadolinium-based compounds; and * evaluate which MRI pulse-sequences maximise sensitivity for macrophage imaging with ferucarbotran in the setting of acute myocardial infarction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ferucarbotran (Resovist) | single time intravenous bolus injection of a contrast agent |
Timeline
- Start date
- 2009-03-01
- Primary completion
- 2010-03-01
- First posted
- 2009-04-23
- Last updated
- 2014-11-07
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00886444. Inclusion in this directory is not an endorsement.